Z医药有限公司企业文化建设研究

发布时间：2018-01-31 16:00

本文关键词： Z医药企业文化建设测量　出处：《广东财经大学》2017年硕士论文　论文类型：学位论文

【摘要】：Z医药有限公司(简称“Z医药”)于1951年组建,是我国规模最大的合资药企,其由“广药集团”与全球500强“联合博姿”共同投资所创建,下属成员企业包括健民、欣特、器化、国盈医药等子公司共22家。该公司在2015年共实现378.23亿元的销售收入,相较于上年度实现了12.8%的增幅,利润同比实现了7.17%的增幅。然而,尽管企业发展较为良好,但因竞争的加剧、市场环境的较大变化及愈加增大的员工年龄断层的影响,加之逐步增加的配送中心与异地成员企业,使得Z医药的管理层愈加认识到在公司管理中文化力所发挥的重大作用。经历65年的发展,Z医药已实现具有自身独特性的企业文化的构建,这样的文化基础能够从何种层面推动公司的发展?要使企业文化理念真正为员工所认同,并实现其自觉践行与遵守,需要对文化体系进行怎样的梳理?又应该怎样对新并购企业实施文化整合?Z医药应如何与自身发展特点相结合,进行发展企业文化的规划与战略的制定,进而推动企业文化的传承与发展?论文以上述问题为对象,并与Z医药的现实相结合,根据涵盖公平奖惩、社会责任、关心员工、人际和谐、规范整合、勇于创新、顾客导向等内容的企业文化量表进行诊断与评估,深入剖析与研究该司企业文化建设所存在的问题及积累的优秀经验,以为企业文化建设的完善提供有效的借鉴。其次,以诊断结果为依据,针对Z企业医药文化的提升制定了相应的对策及可行性方案。最后,对论文进行总结,提出Z医药应以“一个Z医药”为核心,进行战略目标、企业文化、品牌形象、战略布局、绩效管理、企业能力等内容的构建与完善。本论文以Z医药企业文化建设为对象进行了发展路径的探寻,为同行业企业的发展提供了有效的借鉴。
[Abstract]:Z Pharmaceutical Co., Ltd. (referred to as "Z Medicine") was established in 1951, is the largest joint venture pharmaceutical enterprise in China, which was founded by the "Guang Pharmaceutical Group" and the Global Top 500 "combined Bozi" co-investment. The subsidiary companies include Jianmin, Hint, Qihua, Guoying Pharmaceutical Co., Ltd. In 2015, the company achieved a total sales income of thirty-seven billion eight hundred and twenty-three million yuan. Profits rose by 7.17% from a year earlier, compared with an increase of 12.8% in the previous year. However, despite better corporate growth, competition has intensified. Greater changes in the market environment and the growing age gap of employees, coupled with a gradual increase in distribution centers and foreign member enterprises. The management of Z medicine has become more aware of the important role of cultural power in the management of the company. After 65 years of development, Z medicine has realized the construction of its own unique corporate culture. At what level can such a cultural foundation contribute to the development of the company? In order to make the concept of corporate culture truly recognized by the employees and to realize its conscious practice and compliance, what kind of sort of cultural system should be combed? And how to implement the cultural integration of new M & A enterprises? How to combine Z medicine with its own development characteristics to develop corporate culture planning and strategy, and then promote the inheritance and development of corporate culture? The paper takes the above problems as the object and combines with the reality of Z medicine, according to the cover of fair reward and punishment, social responsibility, care for employees, interpersonal harmony, normative integration, dare to innovate. Customer orientation and other content of corporate culture scale for diagnosis and evaluation, in-depth analysis and study of the division's corporate culture construction problems and accumulated outstanding experience. For the improvement of corporate culture construction to provide an effective reference. Secondly, based on the diagnosis results, for the promotion of medical culture in Z enterprise to formulate the corresponding countermeasures and feasibility plans. Finally, the paper summarized. It is pointed out that Z medicine should take "one Z medicine" as the core, and carry out strategic objectives, corporate culture, brand image, strategic layout and performance management. This paper takes Z pharmaceutical enterprise culture construction as the object to explore the development path, which provides an effective reference for the development of the same industry enterprises.
【学位授予单位】：广东财经大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72;F270

【参考文献】